Subject: Manufacturer of anti-cancer and high-risk pharmaceutical raw materials in three categories of active raw material (API), semi-finished (Semi Finished) and final products (Finished Dosage)

Province: Alborz

Address: No.611, Dr. Hesabi West Street, Aboureihan Blvd., Eshtehard Industrial Town, Karaj - IRAN

Phone: 026 - 37 77 30 68 ، 021 - 22 13 46 21 ، 021 - 22 07 25 71

Fax: 021 - 22 13 46 21

More Information: Baran Chemical and Pharmaceutical Company is one of the DAKPHA Holding companies. This Holding which is based on committed professionals and modern equipment and technology, carries out its mission in developing the pharmaceutical raw materials industry and various forms of medicine and meeting the needs of the community and promoting public health level. Other subsidiary companies of this holding are "Danesh Pharmaceutical Development" and "Alborz Pharmed".
API
- Capecitabine : Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
- Regorafenib : Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumours. FDA approved on September 27, 2012.
- Imatinib : Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is occasionally referred to as CGP57148B or STI571 (especially in older publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies.